Literature DB >> 12752584

Characterization of wheezing phenotypes in the first 10 years of life.

R J Kurukulaaratchy1, M H Fenn, L M Waterhouse, S M Matthews, S T Holgate, S H Arshad.   

Abstract

BACKGROUND: Childhood wheezing illnesses are characterized into different phenotypes. However, severity of the disease associated with these phenotypes has not been extensively studied.
OBJECTIVES: To determine characteristics of childhood wheezing phenotypes in the first decade of life using health outcomes plus measurements of atopy, lung function and bronchial hyper-responsiveness.
METHODS: A whole population birth cohort (n = 1456) was prospectively studied to examine the natural history of childhood wheezing. Children were seen at 1, 2, 4 and 10 years for questionnaire completion and prospectively collected data used to define wheezing phenotypes. Assessment was made of adverse health outcomes plus spirometry, bronchial hyper-responsiveness, serum IgE measurement at 10 years and skin test sensitization at both 4 and 10 years for wheezing phenotypes.
RESULTS: Phenotypic analysis identified that 37% early life wheezers (symptom onset by age 4 years) still wheezed at 10 years. These persistent wheezers showed significantly more physician-diagnosed asthma in early life (P < 0.005 at 2 years) than early transient wheezers (wheezing transiently with onset by age 4 years). Overall they experienced greater multiple hospital admissions (P = 0.024), specialist referral (P = 0.009) and use of inhaled (P < 0.001) and oral steroids (P < 0.001) than early transient wheezers. They also demonstrated enhanced bronchial hyper-responsiveness compared with early transient wheezers (P < 0.001). However, both groups of early life wheezers showed impairment of baseline lung function at 10 years in comparison with non-wheezers: FEV1 (P < 0.029) and FEV1/FVC ratio (P < 0.001) with persistent wheeze and PEF (P = 0.036) with early transient wheeze. Late-onset wheezers (onset from 5 years onwards) had similar BHR to persistent wheezers but maintained normal lung function at age 10 and had lower cumulative prevalence of adverse health outcomes than persistent wheezers.
CONCLUSIONS: Persistent wheezing with early childhood onset is associated with substantial morbidity in the first decade of life in association with high levels of atopy, bronchial hyper-responsiveness and impaired lung function at 10 years of age. Late-onset wheezing in the first decade of life could harbour potential for similarly significant disease subsequently.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752584     DOI: 10.1046/j.1365-2222.2003.01657.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  49 in total

1.  Linkage analysis of a cluster-based quantitative phenotype constructed from pulmonary function test data in 27 multigenerational families with multiple asthmatic members.

Authors:  Cavan Reilly; Michael B Miller; Yuhong Liu; William S Oetting; Richard King; Malcolm Blumenthal
Journal:  Hum Hered       Date:  2007-05-04       Impact factor: 0.444

2.  Prognostic values of specific respiratory sounds for asthma in adolescents.

Authors:  Theresa Hunger; Peter Rzehak; H-Erich Wichmann; Joachim Heinrich
Journal:  Eur J Pediatr       Date:  2009-03-25       Impact factor: 3.183

3.  Filaggrin mutations increase allergic airway disease in childhood and adolescence through interactions with eczema and aeroallergen sensitization.

Authors:  Adrian Chan; William Terry; Hongmei Zhang; Wilfried Karmaus; Susan Ewart; John W Holloway; Graham Roberts; Ramesh Kurukulaaratchy; Syed Hasan Arshad
Journal:  Clin Exp Allergy       Date:  2018-02       Impact factor: 5.018

4.  Relationship between maternal demoralization, wheeze, and immunoglobulin E among inner-city children.

Authors:  Marilyn Reyes; Matthew S Perzanowski; Robin M Whyatt; Elizabeth A Kelvin; Andrew G Rundle; Diurka M Diaz; Lori Hoepner; Frederica P Perera; Virginia Rauh; Rachel L Miller
Journal:  Ann Allergy Asthma Immunol       Date:  2011-04-14       Impact factor: 6.347

5.  Delivery by Cesarean section and early childhood respiratory symptoms and disorders: the Norwegian mother and child cohort study.

Authors:  Maria C Magnus; Siri E Håberg; Hein Stigum; Per Nafstad; Stephanie J London; Siri Vangen; Wenche Nystad
Journal:  Am J Epidemiol       Date:  2011-10-29       Impact factor: 4.897

6.  Prenatal and postnatal bisphenol A exposure and asthma development among inner-city children.

Authors:  Kathleen M Donohue; Rachel L Miller; Matthew S Perzanowski; Allan C Just; Lori A Hoepner; Srikesh Arunajadai; Stephen Canfield; David Resnick; Antonia M Calafat; Frederica P Perera; Robin M Whyatt
Journal:  J Allergy Clin Immunol       Date:  2013-03       Impact factor: 10.793

7.  Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study.

Authors:  Kim D G van de Kant; Ester M M Klaassen; Quirijn Jöbsis; Annedien J Nijhuis; Onno C P van Schayck; Edward Dompeling
Journal:  BMC Public Health       Date:  2009-06-29       Impact factor: 3.295

8.  Birth order modifies the effect of IL13 gene polymorphisms on serum IgE at age 10 and skin prick test at ages 4, 10 and 18: a prospective birth cohort study.

Authors:  Ikechukwu U Ogbuanu; Wilfried J Karmaus; Hongmei Zhang; Tara Sabo-Attwood; Susan Ewart; Graham Roberts; Syed H Arshad
Journal:  Allergy Asthma Clin Immunol       Date:  2010-04-20       Impact factor: 3.406

9.  Relationships between age of puberty onset and height at age 18 years in girls and boys.

Authors:  Mitra Yousefi; Wilfried Karmaus; Hongmei Zhang; Graham Roberts; Sharon Matthews; Bernie Clayton; Syed Hasan Arshad
Journal:  World J Pediatr       Date:  2013-01-18       Impact factor: 2.764

10.  A disease model for wheezing disorders in preschool children based on clinicians' perceptions.

Authors:  Ben D Spycher; Michael Silverman; Juerg Barben; Ernst Eber; Stéphane Guinand; Mark L Levy; Caroline Pao; Willem M van Aalderen; Onno C P van Schayck; Claudia E Kuehni
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.